Regeneron Pharmaceuticals, Inc. (REGN)
828.72
-5.32
(-0.64%)
USD |
NASDAQ |
Aug 24, 16:00
834.55
+5.83
(+0.70%)
After-Hours: 20:00
Regeneron Pharmaceuticals EPS Diluted (Quarterly) : 12.23 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.23 |
| March 31, 2026 | 6.752 |
| December 31, 2025 | 7.857 |
| September 30, 2025 | 13.62 |
| June 30, 2025 | 12.81 |
| March 31, 2025 | 7.272 |
| December 31, 2024 | 8.064 |
| September 30, 2024 | 11.54 |
| June 30, 2024 | 12.41 |
| March 31, 2024 | 6.273 |
| December 31, 2023 | 10.19 |
| September 30, 2023 | 8.887 |
| June 30, 2023 | 8.502 |
| March 31, 2023 | 7.174 |
| December 31, 2022 | 10.50 |
| September 30, 2022 | 11.66 |
| June 30, 2022 | 7.475 |
| March 31, 2022 | 8.607 |
| December 31, 2021 | 19.69 |
| September 30, 2021 | 14.33 |
| June 30, 2021 | 27.97 |
| March 31, 2021 | 10.09 |
| December 31, 2020 | 10.24 |
| September 30, 2020 | 7.393 |
| June 30, 2020 | 7.611 |
| Date | Value |
|---|---|
| March 31, 2020 | 5.43 |
| December 31, 2019 | 6.929 |
| September 30, 2019 | 5.863 |
| June 30, 2019 | 1.685 |
| March 31, 2019 | 3.99 |
| December 31, 2018 | 7.15 |
| September 30, 2018 | 5.17 |
| June 30, 2018 | 4.82 |
| March 31, 2018 | 4.16 |
| December 31, 2017 | 1.50 |
| September 30, 2017 | 3.32 |
| June 30, 2017 | 3.34 |
| March 31, 2017 | 2.16 |
| December 31, 2016 | 2.19 |
| September 30, 2016 | 2.27 |
| June 30, 2016 | 1.69 |
| March 31, 2016 | 1.59 |
| December 31, 2015 | 1.34 |
| September 30, 2015 | 1.82 |
| June 30, 2015 | 1.69 |
| March 31, 2015 | 0.66 |
| December 31, 2014 | 0.96 |
| September 30, 2014 | 0.70 |
| June 30, 2014 | 0.82 |
| March 31, 2014 | 0.58 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Gilead Sciences, Inc. | -8.444 |
| AbbVie, Inc. | 2.033 |
| Vertex Pharmaceuticals, Inc. | 4.310 |
| Amgen, Inc. | 4.366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.297B |
| Revenue (Quarterly) | 4.291B |
| Total Expenses (Quarterly) | 2.994B |
| Enterprise Value | 80.94B |
| Gross Profit Margin (Quarterly) | 83.68% |
| Profit Margin (Quarterly) | 30.23% |
| Earnings Yield | 4.88% |
| Operating Earnings Yield | 4.70% |
| Normalized Earnings Yield | 5.176 |